Stanford L. Peng

Officer, Alpine Immune Sciences.

Companies

Alpine Immune SciencesOfficer Jul 26, 2017 to May 20, 2024¹
Alpine Immune SciencesPresident Jan 27, 2020 to Jan 27, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Recent filings

May 20, 2024Returned to company 48,000 shares of CIK 1626199³
May 20, 2024Returned to company 296,163 shares of CIK 1626199³
May 8, 2024Exercised options 13,377 shares at $6.33 of CIK 1626199⁴
May 8, 2024Exercised options 26,912 shares at $3.23 of CIK 1626199⁴
May 8, 2024Exercised options 22,593 shares at $11.31 of CIK 1626199⁴
May 8, 2024Exercised options 161,492 shares at $0.65 of CIK 1626199⁴
May 8, 2024Exercised options 37,267 shares at $0.65 of CIK 1626199⁴
May 8, 2024Exercised options 3,126 shares at $6.51 of CIK 1626199⁴
May 8, 2024Exercised options 7,025 shares at $13.20 of CIK 1626199⁴
Jan 4, 2024Granted 48,000 shares of CIK 1626199⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAlpine Immune Sciences, Officer
2
SEC EDGARAlpine Immune Sciences, President
3
SEC EDGARForm 4 filed May 20, 2024
4
SEC EDGARForm 4 filed May 10, 2024
5
SEC EDGARForm 4 filed Jan 5, 2024